Details for Patent: 7,101,569
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,101,569 protect, and when does it expire?
Patent 7,101,569 protects LEVOXYL and is included in one NDA.
This patent has twenty-six patent family members in nine countries.
Summary for Patent: 7,101,569
Title: | Methods of administering levothyroxine pharmaceutical compositions |
Abstract: | The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions. |
Inventor(s): | Franz; G. Andrew (St. Louis, MO), Strauss; Elaine A. (Seminole, FL), DiMenna; Phillip A. (St. Petersburg, FL), Gemma; Rocco L. (Dover, OH) |
Assignee: | |
Application Number: | 10/218,718 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 7,101,569
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-001 | May 25, 2001 | AB1,AB3 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF USE OF ADMINISTERING LEVOTHYROXINE | See Plans and Pricing | |||
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-002 | May 25, 2001 | AB1,AB3 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF USE OF ADMINISTERING LEVOTHYROXINE | See Plans and Pricing | |||
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-003 | May 25, 2001 | AB1,AB3 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF USE OF ADMINISTERING LEVOTHYROXINE | See Plans and Pricing | |||
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-004 | May 25, 2001 | AB1,AB3 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF USE OF ADMINISTERING LEVOTHYROXINE | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,101,569
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2002240394 | See Plans and Pricing | |||
Australia | 2002258397 | See Plans and Pricing | |||
Australia | 2002332507 | See Plans and Pricing | |||
Australia | 2002341555 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |